News
More than 50% price cut for Bayer's Long-Acting Reversible Contraceptive Implant
29th March 201327 February 2013, Leverkusen, Germany – An unprecedented group of public and private sector partners has finalized an agreement that will make Jadelle®, an effective, long-acting, reversible contraceptive implant, available to more than 27 million women in the world's poorest countries at a more than 50 percent price reduction over the next six years.
Category: Featured
Bayer's new reporting mechanism
21st February 2013Clients can report adverse reaction
Category: Featured
Groundbreaking Rights Webinar
12th February 2013Global South participants in the majority
Category: Featured
Webinar: Voluntary, Human Rights-based FP Work
6th February 201312 February 2013
Category: Featured
LAPTOP Scholar speaks to the Coalition
28th January 2013A TV programme changed Dr. Kossivi Afanvi's life
Category: Featured